Novartis (NOTA) Stock Statistics & Valuation Metrics

Novartis has a market cap or net worth of €192.23B. The enterprise value is €262.89B.

Novartis has 2,112,421,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Novartis’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 15.55%.

The current PE Ratio of Novartis is 15.0. Novartis’s PEG ratio is ―.

In the last 12 months, Novartis had revenue of 51.72B and earned 11.94B in profits. Earnings per share was 5.92.

In the last 12 months, operating cash flow was 20.79B and capital expenditures -3.98B, giving a free cash flow of 16.81B billion.

Novartis pays an annual dividend of €2.17, resulting in a dividend yield of 3.59%

Novartis upcoming earnings date is Oct 28, 2025, TBA (Confirmed).

Novartis as a current ratio of 1.04, with Debt / Equity ratio of 81.50%

In the past 12 months, Novartis has paid 1.70B in taxes.

Novartis EV to EBITDA ratio is 10.44, with an EV/FCF ratio of 15.66.

Novartis has €7.00B in cash and marketable securities with €32.64B in debt, giving a net cash position of €25.64B billion.

Gross margin is 75.65%, with operating margin of 28.12%, and net profit margin of 23.09%.

The average price target for Novartis is €106.33, which is 11.43% higher than the current price. The consensus rating is Hold